Streamlined Medicine Approval In New Zealand Will Benefit Drugmakers, But Risks In Securing Public Funding Remain
Pharmaceuticals / New Zealand / Fri 08 Mar, 2024
Key View
- New Zealand’s initiative to fast-track medicine approvals will drive commercial opportunities for drugmakers.
- The new time limits for approvals will help to correct historical lags in market access and incentivise drugmakers to launch products in New Zealand.
- While the government remains keen to widen access to patented